Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-001135
Filing Date
2012-01-26
Accepted
2012-01-26 19:52:04
Documents
2
Period of Report
2012-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 7469
2 WESTPHAL POA ex24westphal.txt EX-24.TXT 4500
  Complete submission text file 0001179110-12-001135.txt   13343
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35403 | Film No.: 12548863

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations